4 stocks to watch on Thursday: ADBE, KMB and more [Seeking Alpha]
Sarepta Therapeutics, Inc. (SRPT)
Last sarepta therapeutics, inc. earnings: 2/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investorrelations.sarepta.com/events-and-presentations
Company Research
Source: Seeking Alpha
session, but its blue-chip average looked set to add onto losses. Here are some stocks to watch on Thursday: Adobe ( ADBE ) stock will be in focus, with the creative software maker on tap to announce FQ2 2024 results after the closing bell. Wall Street expects Adobe ( ADBE ) to earn $4.39 per share on revenue of $5.29B. The San Jose, Calif.-based company - known for its Photoshop graphics editor and Premier Pro video editor - is facing questions around just how well it can monetize its artificial intelligence (AI) offerings, such as its generative AI tool Firefly. Investors will be closely looking out for comments around that. Oppenheimer last week said it sensed that investors were "shifting opinions of Adobe ( ADBE ) as an AI winner to fears about competition from AI." Shares of Pfizer ( PFE slipped marginally in pre-market trading, after the company said a late-stage trial evaluating its investigational gene therapy for the treatment of ambulatory boys with a type of muscle was
Show less
Read more
Impact Snapshot
Event Time:
SRPT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SRPT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SRPT alerts
High impacting Sarepta Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
SRPT
News
- Global Cell and Gene Therapy CRO Market Research 2024-2035: Over 105 CROs Drive Innovations with 80% Ensuring Comprehensive Support from R&D to Clinical Trials [Yahoo! Finance]Yahoo! Finance
- Parent Project Muscular Dystrophy Hosts 30th Annual Conference in Orlando, Florida [Yahoo! Finance]Yahoo! Finance
- Sarepta Therapeutics, Inc. (NASDAQ: SRPT) had its price target raised by analysts at Evercore ISI from $139.00 to $185.00. They now have an "in-line" rating on the stock.MarketBeat
- Sarepta Therapeutics, Inc. (NASDAQ: SRPT) had its price target raised by analysts at SVB Leerink LLC from $165.00 to $230.00. They now have an "outperform" rating on the stock.MarketBeat
- Sarepta Therapeutics, Inc. (NASDAQ: SRPT) had its price target raised by analysts at BMO Capital Markets from $170.00 to $200.00. They now have an "outperform" rating on the stock.MarketBeat
SRPT
Earnings
- 5/1/24 - Beat
SRPT
Sec Filings
- 6/25/24 - Form 4
- 6/25/24 - Form 4
- 6/25/24 - Form 4
- SRPT's page on the SEC website